Presentation is loading. Please wait.

Presentation is loading. Please wait.

The future of renoprotection: Frustration and promises

Similar presentations


Presentation on theme: "The future of renoprotection: Frustration and promises"— Presentation transcript:

1 The future of renoprotection: Frustration and promises
Arrigo Schieppati, Giuseppe Remuzzi  Kidney International  Volume 64, Issue 6, Pages (December 2003) DOI: /j x Copyright © 2003 International Society of Nephrology Terms and Conditions

2 Figure 1 Schematic representation of podocyte disfunction caused by protein overload in chronic nephropathies. Abbreviations are: ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blockers; TGF-β, transforming growth factor-β. Kidney International  , DOI: ( /j x) Copyright © 2003 International Society of Nephrology Terms and Conditions

3 Figure 2 Algorithm of the remission clinic for chronic nephropathies. In the box the targets for remission clinic are reported. Abbreviations are: ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blockers. CCB, calcium channel blockers; LDL, low-density lipoprotein; VLDL, very low-density lipoprotein; HbA1c, hemoglobin A1c. Kidney International  , DOI: ( /j x) Copyright © 2003 International Society of Nephrology Terms and Conditions


Download ppt "The future of renoprotection: Frustration and promises"

Similar presentations


Ads by Google